Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars
HB 529 requires health insurers, HMOs, and nonprofit health plans in Maryland to post their prescription drug coverage lists (formularies) clearly on their websites without requiring login or account access. Insurers must display drug tiering, coverage restrictions, and update changes within 30 days of implementation. The bill also mandates that these insurers cover certain generic drugs and biosimilars with specific cost-sharing terms (e.g., copays or coinsurance). This directly affects all health plan providers operating in Maryland and makes drug coverage information more transparent for enrollees.
Bill status
died
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 22, 2025
Last action Feb 17, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
1
Jan 22, 2025
Committee
First Reading Health and Government Operations
lower
5 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Andrea Harrison
DDemocratic
P
Deni Taveras
DDemocratic
P
Jen Terrasa
DDemocratic
P
Mary Lehman
DDemocratic
P
Natalie Ziegler
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 529
Scope: MD
Hi! I can help you understand HB 529. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline